Lecture 2 - 6/30/2022 Flashcards

1
Q

Factors Determining CS Schedule

A

(1) Its actual or relative potential for abuse;
(2) Scientific evidence of its pharmacological effect, if known;
(3) The state of current scientific knowledge regarding the drug or other substance;
(4) Its history and current pattern of abuse;
(5) The scope, duration, and significance of abuse;
(6) What, if any, risk there is to the public health;
(7) Its psychic or physiological dependence liability; and
(8) Whether the substance is an immediate precursor of a substance already controlled under this subchapter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Schedule I info

A
  1. high abuse potential
  2. no current acceptable medical treatment in US
  3. no acceptable info regarding safety…even under medical supervision
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Schedule II info

A
  1. high abuse potential
  2. accepted medical use ( may have severe restrictions)
  3. Abuse may lead to sever physical & Psychological dependence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Schedule III info

A
  1. Less abuse potential than CI & CII
  2. currently acceptable medical treatment in US
  3. Abuse may lead to moderate or low physical dependence or high psychological dependence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Schedule IV info

A
  1. low potential of abuse relative to CIII
  2. current acceptable medical treatment in US
  3. Abuse may lead to limited physical dependence or high psychological dependence relative to CIII
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Schedule V info

A
  1. Low abuse potential
  2. Current acceptable medical treatment in US
    Abuse may lead to limited physical dependence or high psychological dependence relative to CIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A Schedule V drug cannot contain more than…..

A
  1. 200 mg of codeine per 100mL or 100 g
  2. 100mg of dihydrocodeine, ethylmorphine, or opium per 100mL or 100g
  3. 2.5mg of diphenoxylate and not less than 25mcg of atropine per dosage unit
  4. 0.5mg of difenoxin and not less than 25mch of atropine sulfate per dosage unit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Controlled substance Registration

A

21 USC 822

  1. Closed system of Distribution = only registrants may engage in manufacturing, distribution and dispensing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how often do manufactures & Distributors need to renew registration

A

annual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How often do dispensers need to renew registration

A

every 3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Exceptions to controlled substance registration

A
  1. agent or employee of a registered manufacturer, distributor, dispenser acting in the normal course of business or employment
  2. common carrier contact carrier or warehouseman acting in normal course of business or employment
  3. ultimate user who possess the CS for lawful purpose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Activates that require DEA CS registration

A
Manufacturing
Distributing
Reverse Distributing
Dispensing or instructing (includes Practitioner, Hospital/ Clinic, Retail Pharmacy, Central fill pharmacy, Teaching Institution)
Research (CI) and Research (CII-V) 
Narcotic Treatment Program (including compounder)
Importing
Exporting
Chemical Analysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DEA Form 224 is….

A

Application for registration for Dispenser

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DEA Form 225 is…

A

Application for registration for Manufacturers, Distributors, Narcotic Treatment Programs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How to validate DEA number

A

Step 1: add the first, third, and fifth digits of the DEA number

Step 2: add the second, fourth, and sixth digits of the DEA number and multiply by 2

Step 3: add the result of Step 1 to the result of Step 2- the last digit must be the same as the last digit of the DEA number.

Example: DEA number AB7258367
Step 1: 7 + 5 + 3 = 15
Step 2: 2 + 8 + 6 = 16 x 2 = 32
Step 3: 15 + 32 = 47

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

1st letter DEA =

A

code identifying type of registrant

17
Q

2nd letter of DEA =

A

1st letter of registrants last name or business name

18
Q

A =

A

Deprecated (used by older entities)

19
Q

B =

A

Hospital / Clinic

20
Q

C =

A

Practitioner

21
Q

D =

A

Teaching Insitution

22
Q

E =

A

Manufacturer

23
Q

F =

A

Distributor

24
Q

G =

A

Researcher

25
Q

H =

A

Analytical Lab

26
Q

J =

A

Importer

27
Q

K =

A

Exporter

28
Q

L =

A

Reverse Distributor

29
Q

M =

A

Mid level practitioner

30
Q

N =

A

Military practitioner

31
Q

P, T, R, S, U =

A

Narcotic Treatment Program

32
Q

X =

A

Suboxone/Subutex Prescribing Program

33
Q

DEA 223 form is…

A

issued as the CS registration ( CII-CV) if application approved by DEA

34
Q

DEA 222 form is….

A

used to order drugs CI-CII

35
Q

CS: Security Requirements

A

21 CFR 1301.71(a)

Registrants must provide effective controls and procedures to guard against theft and diversion of controlled substances

Some factors used in evaluating effective security controls and procedures:

The type of activity conducted (e.g., processing of bulk chemicals, preparing dosage forms, packaging,

  • labeling, cooperative buying, etc.);
  • the type and form of controlled substances handled;
  • the quantity of controlled substance handled;
  • location of the premises
  • type of building (and general characteristics)
  • the type of closures on vaults, safes, and secure enclosures
  • Adequacy of lock control system
  • Adequacy of alarms
36
Q

MA controlled Substance Security:

A

247 CMR 6.02 (6)

  1. All Controlled substances (C2-C5) must be stored in pharmacy area
  2. Controlled substances in C6 maybe stored in pharmacy area or in a clean room adjacent to pharmacy area
  3. C2-C5 shall be locked in substantially constructed cabinet or dispersed throughout C6 stock in a manner designed to reduce risk of diversion